Decreased concentration of il-35 in plasma of patients with asthma and COPD

Asian Pacific Journal of Allergy and Immunology

Volumn 32, Issue 3, 2014, Pages 211-217

  Chen, Chen ^a   Deng, Yanhan ^a   Chen, Huilong ^a   Wu, Xiaojie ^a   Cheng, Sheng ^a   Xu, Yongjian ^a   Xiong, Weining ^a   Xie, Jungang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Asthma; COPD; Cytokine; IL 35; Pulmonary function

Indexed keywords

INTERLEUKIN 35; INTERLEUKIN DERIVATIVE; INTERLEUKIN-35, HUMAN;

ADOLESCENT; ADULT; AGE; ARTICLE; ASTHMA; BLOOD SAMPLING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENDER; HUMAN; INFLAMMATION; LUNG FUNCTION; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW; PHYSICAL EXAMINATION; PROTEIN EXPRESSION; QUESTIONNAIRE; SMOKING; TH17 CELL; TH2 CELL; BLOOD; CLINICAL TRIAL; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ADOLESCENT; ADULT; ASTHMA; FEMALE; HUMANS; INFLAMMATION; INTERLEUKINS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TH17 CELLS; TH2 CELLS;

EID: 84911901461     PISSN: 0125877X     EISSN: 22288694     Source Type: Journal    
DOI: 10.12932/AP0403.32.3.2014     Document Type: Article

References (30)

1. Fang X, Wang X, Bai C. COPD in China: the burden and importance of proper management. Chest. 2011;139:920-9.
2. Gibson PG, Simpson JL, Saltos N. Heterogeneity of airway inflammation in persistent asthma:evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest. 2001;119:1329-36.
3. Lloyd CM, Hawrylowicz CM. Regulatory T cells in asthma. Immunity. 2009;31:438-49.
4. Larche M. Regulatory T cells in allergy and asthma. Chest 2007;132:1007-14.
5. Strickland DH, Holt PG. T regulatory cells in childhood asthma. Trends Immunol. 2011;32:420-7.
6. Gibson PG, Fujimura M, Niimi A. Eosinophilic bronchitis: clinical manifestations and implications for treatment. Thorax. 2002;57:178-82.
7. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 2008;8:183-92.
8. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature. 2007;450:566-9.
9. Collison LW, Vignali DA. Interleukin-35: odd one out or part of the family? Immunol Rev. 2008;226:248-62.
10. Huang CH, Loo EX, Kuo IC, Soh GH, Goh DL, Lee BW, et al. Airway inflammation and IgE production induced by dust mite allergen-specific memory/effector Th2 cell line can be effectively attenuated by IL-35. J Immunol. 2011;187:462-71.
11. Botelho FM, Llop-Guevara A, Trimble NJ, Nikota JK, Bauer CM, Lambert KN, et al. Cigarette smoke differentially affects eosinophilia and remodeling in a model of house dust mite asthma. Am J Respir Cell Mol Biol. 2011;45:753-60.
12. Bullens DM, Ceuppens JL. Influence of Toll-like-receptor ligands on the dendritic cell-T cell interactions: therapeutic options for allergic diseases? Mini-review. Inflamm Allergy Drug Targets. 2008;7:211-6.
13. Devergne O, Hummel M, Koeppen H, Le Beau MM, Nathanson EC, Kieff E, et al. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J Virol. 1996;70:1143-53.
14. Liu F, Tong F, He Y, Liu H. Detectable expression of IL-35 in CD4+ T cells from peripheral blood of chronic hepatitis B patients. Clin Immunol. 2011;139:1-5.
15. Lin Y, Huang Y, Lu Z, Luo C, Shi Y, Zeng Q, et al. Decreased plasma IL-35 levels are related to the left ventricular ejection fraction in coronary artery diseases. PLoS One. 2012;7:e52490.
16. Niedbala W, Wei XQ, Cai B, Hueber AJ, Leung BP, McInnes IB, et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol. 2007;37:3021-9.
17. Wirtz S, Billmeier U, Mchedlidze T, Blumberg RS, Neurath MF. Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis. Gastroenterology. 2011;141:1875-86.
18. Kuo J, Nardelli DT, Warner TF, Callister SM, Schell RF. Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and -infected mice. Clin Vaccine Immunol. 2011;18:1125-32.
19. Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, Bankoti J, et al.. IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol. 2010;11:1093-101.
20. Seyerl M, Kirchberger S, Majdic O, Seipelt J, Jindra C, Schrauf C, et al.. Human rhinoviruses induce IL-35-producing Treg via induction of B7-H1 (CD274) and sialoadhesin (CD169) on DC. Eur J Immunol. 2010;40:321-9.
21. Langhans B, Braunschweiger I, Arndt S, Schulte W, Satoguina J, Layland LE, et al. Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C. Clin Sci (Lond). 2010;119:97-109.
22. Li X, Mai J, Virtue A, Yin Y, Gong R, Sha X, et al. IL-35 is a novel responsive anti-inflammatory cytokine--a new system of categorizing anti-inflammatory cytokines. PLoS One. 2012;7:e33628.epub33628.
23. Ning-Wei Z. Interleukin (IL)-35 is raising our expectations. Rev Med Chil. 2010;138:758-66.
24. Goriely S, Goldman M. Interleukin-12 family members and the balance between rejection and tolerance. Curr Opin Organ Transplant. 2008;13:4-9.
25. Yoshida H, Miyazaki Y. Regulation of immune responses by interleukin-27. Immunol Rev. 2008;226:234-47.
26. Li K, Wang Z, Cao Y, Bunjhoo H, Zhu J, Chen Y, et al. The study of the ratio and distribution of Th17 cells and Tc17 cells in asthmatic patients and the mouse model. Asian Pac J Allergy Immunol. 2013;31:125-31.
27. Vignali DA, Kuchroo VK. IL-12 family cytokines: immunological playmakers. Nat Immunol. 2012;13:722-8.
28. Saetta AA, Gigelou F, Papanastasiou PI, Koilakou SV, Kalekou-Greca H, Miliaras D, et al. High-level microsatellite instability is not involved in gallbladder carcinogenesis. Exp Mol Pathol. 2006;80:67-71.
29. Saetta AA, Aroni K, Stamatelli A, Lazaris AC, Patsouris E. Expression of mismatch repair enzymes, hMLH1 and hMSH2 is not associated with microsatellite instability and P53 protein accumulation in basal cell carcinoma. Arch Dermatol Res. 2005;297:99-107.
30. Manuyakorn W, Howarth PH, Holgate ST. Airway remodelling in asthma and novel therapy. Asian Pac J Allergy Immunol. 2013;31:3-10.